Zosuquidar Trihydrochloride is a potent, selective P-glycoprotein (P-gp/ABCB1) inhibitor primarily investigated for its ability to reverse multidrug resistance in cancer therapy. By blocking the ATP-dependent… Read more
Zosuquidar Trihydrochloride is a potent, selective P-glycoprotein (P-gp/ABCB1) inhibitor primarily investigated for its ability to reverse multidrug resistance in cancer therapy. By blocking the ATP-dependent efflux pump that cancer cells use to expel chemotherapeutic agents, this compound aims to restore cellular sensitivity to antineoplastic treatments. To support rigorous pharmaceutical research and development, high-quality reference standards are essential. This collection includes pharmacopeial and non-pharmacopeial impurities, synthetic metabolites, and stable isotope labelled compounds critical for comprehensive impurity profiling. Laboratories utilize these precise materials for analytical method validation, ensuring accurate quantification and consistent quality control throughout the lifecycle of drug substance development. These standards are instrumental for researchers studying transporter-mediated pharmacokinetics and establishing robust analytical procedures in oncological drug research.